Until now, there is no effective approach to stop the progression of multiple sclerosis and
stimulate re-myelination. Autologous stem cell transplantation shows hope and is quickly
developing as an alternative therapy. We propose the use of autologous bone marrow-derived
specific stem cell populations and mesenchymal stem cell transplantation (BM-MSC) associated
with immuno-modulation to treat patients with relapsing-remitting MS (RRMS).